Oswald Burkhard

890 total citations
30 papers, 663 citations indexed

About

Oswald Burkhard is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Oswald Burkhard has authored 30 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 8 papers in Oncology and 7 papers in Genetics. Recurrent topics in Oswald Burkhard's work include Hemoglobin structure and function (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Oswald Burkhard is often cited by papers focused on Hemoglobin structure and function (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Oswald Burkhard collaborates with scholars based in Germany, Switzerland and United Kingdom. Oswald Burkhard's co-authors include W. Liptay, Barbara Eichhorst, Martina Stauch, Clemens‐Martin Wendtner, Raymonde Busch, Bertold Emmerich, Michael Hallek, Matthias Ritgen, Robert Rohrberg and Manuela A. Bergmann and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Oswald Burkhard

30 papers receiving 638 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Oswald Burkhard Germany	10	294	287	226	120	114	30	663
Heather S. Bonner United States	16	304 1.0×	169 0.6×	234 1.0×	329 2.7×	72 0.6×	24	1.3k
Tadashi Murase Japan	11	45 0.2×	93 0.3×	178 0.8×	122 1.0×	42 0.4×	24	712
William J. Winter United States	7	437 1.5×	192 0.7×	211 0.9×	85 0.7×	53 0.5×	10	625
Dominique Morel France	20	360 1.2×	320 1.1×	147 0.7×	12 0.1×	120 1.1×	36	961
David T. Marshall United States	16	149 0.5×	33 0.1×	196 0.9×	241 2.0×	25 0.2×	38	748
S. Maki Japan	13	36 0.1×	70 0.2×	151 0.7×	186 1.6×	130 1.1×	47	826
Christoph A. Schatz Germany	15	108 0.4×	135 0.5×	525 2.3×	346 2.9×	84 0.7×	47	1.2k
Mark D. Hylarides United States	20	140 0.5×	21 0.1×	259 1.1×	142 1.2×	75 0.7×	49	1.1k
Gunnar Schütz Germany	9	221 0.8×	54 0.2×	530 2.3×	333 2.8×	52 0.5×	15	1.2k
Rajesh R. Nair United States	17	51 0.2×	178 0.6×	239 1.1×	63 0.5×	73 0.6×	42	861

Countries citing papers authored by Oswald Burkhard

Since Specialization

Citations

This map shows the geographic impact of Oswald Burkhard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oswald Burkhard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oswald Burkhard more than expected).

Fields of papers citing papers by Oswald Burkhard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oswald Burkhard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oswald Burkhard. The network helps show where Oswald Burkhard may publish in the future.

Co-authorship network of co-authors of Oswald Burkhard

This figure shows the co-authorship network connecting the top 25 collaborators of Oswald Burkhard. A scholar is included among the top collaborators of Oswald Burkhard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oswald Burkhard. Oswald Burkhard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Weide, Rudolf, et al.. (2024). Metastatic Breast Cancer: Prolonging Life in Routine Oncology Care. Cancers. 16(7). 1255–1255. 1 indexed citations

Pape, Ulrich‐Frank, Stefan Kasper, Marianne Sinn, et al.. (2019). Randomized phase II trial of the carboxylesterase (CES)-converted novel drug EDO-S7.1 in patients (pts) with advanced biliary tract cancers (BTC).. Journal of Clinical Oncology. 37(4_suppl). 264–264. 1 indexed citations

Chakupurakal, Geothy, et al.. (2017). Successful Evidence-Based Treatment of Patients with Advanced Pancreatic Cancer in Community-Based Oncology Group Practices. Oncology Research and Treatment. 40(12). 784–788. 1 indexed citations

Weide, Rudolf, et al.. (2017). Standard of care of patients with Chronic Myeloid Leukemia (CML) treated in community based oncology group practices between 2001-2015 in Rhineland-Palatinate (Germany). SHILAP Revista de lepidopterología. 37(1). 2 indexed citations

Bacher, Ulrike, Torsten Haferlach, Susanne Schnittger, et al.. (2010). Detection of a t(4;14)(p16;q32) in two cases of lymphoma showing both the immunophenotype of chronic lymphocytic leukemia. Cancer Genetics and Cytogenetics. 200(2). 170–174. 6 indexed citations

Eichhorst, Barbara, Raymonde Busch, Stephan Stilgenbauer, et al.. (2009). First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia. Blood. 114(16). 3382–3391. 238 indexed citations

Weide, Rudolf, Jochen Heymanns, H. Gamm, et al.. (2004). Bendamustine/Mitoxantrone/Rituximab (BMR): A Very Effective and Well Tolerated Immuno-Chemotherapy for Relapsed and Refractory Indolent Lymphomas - Results of a Multicentre Phase-II-Study of the German Low Grade Lymphoma Study Group (GLSG).. Blood. 104(11). 2482–2482. 1 indexed citations

Eichhorst, Barbara, Raymonde Busch, Martina Stauch, et al.. (2003). Fludarabine induces higher response rates in first line therapy of older patients with advanced chronic lymphocytic leukemia than chlorambucil Interim analysis of a phase III study of the German CLL Study Group. Blood. 102(11). 10916. 9 indexed citations

Schmitt, Barbara, Astrid Franke, Oswald Burkhard, et al.. (2002). Fludarabine, Mitoxantrone and Cyclophosphamide Combination Therapy in Relapsed Chronic Lymphocytic Leukemia with or without G-CSF Results of the First Interim Ananlysis of a Phase III Study of the German CLL Study Group. Blood. 100(11). 501516. 3 indexed citations

10.

Burkhard, Oswald, et al.. (2002). New artificial oxygen carriers made of pegulated polymerised pyridoxylated porcine haemoglobin (P4Hb). Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology. 132(1). 185–191. 7 indexed citations

11.

Rummel, Mathias, Kai Uwe Chow, T. Karakas, et al.. (2002). Reduced-dose cladribine (2-CdA) plus mitoxantrone is effective in the treatment of mantle-cell and low-grade non-Hodgkin's lymphoma. European Journal of Cancer. 38(13). 1739–1746. 35 indexed citations

12.

Burkhard, Oswald, et al.. (1996). Ein neuartiges Verfahren der Sauerstoffdetektion für Medizin, Biologie, Umweltforschung und Biotechnik auf Basis der Lumineszenzlöschung - An Innovative Procedure for the Detection of Oxygen Based on Luminescence Quenching, for Use in Medicine, Biology, Environmental Research and Biotechnology. Biomedizinische Technik/Biomedical Engineering. 41(6). 170–177. 3 indexed citations

13.

Weh, H.J., H. Wilke, Judith Dierlamm, et al.. (1994). Weekly therapy with folinic acid (FA) and high-dose 5-fluorouracil (5-FU) 24-hour infusion in pretreated patients with metastatic colorectal carcinoma. Annals of Oncology. 5(3). 233–237. 65 indexed citations

14.

Burkhard, Oswald, et al.. (1989). Low Viscosity of Densely and Highly Polymerized Human Hemoglobin in Aqueous Solution — the Problem Of Stability. Advances in experimental medicine and biology. 248. 335–340. 8 indexed citations

15.

Burkhard, Oswald, et al.. (1989). Das Erythrocruorin des Regenwurms (Lumbricus terrestris) als Eichsubstanz in der Gelchromatographie. Journal of Chromatography B Biomedical Sciences and Applications. 497. 231–235. 8 indexed citations

16.

Burkhard, Oswald, et al.. (1988). Huge Compact Soluble Molecules: A New Old Concept to Develop an Oxygen Carrying Blood Substitute. Biomaterials Artificial Cells and Artificial Organs. 16(1-3). 639–642. 10 indexed citations

17.

Burkhard, Oswald, et al.. (1987). Highly Polymerized Human Haemoglobin as an Oxygen-Carrying Blood Substitute. Advances in experimental medicine and biology. 215. 129–134. 9 indexed citations

18.

Detzer, N., et al.. (1987). Model Substances for Electro-optical and Dielectric Studies, Part I Synthesis and Structure of 1,4-Bis(4'-dimethylamino-3',5'-dicyanophenyl)bicyclo[2.2.2]octane. Zeitschrift für Naturforschung B. 42(9). 1129–1141. 6 indexed citations

19.

Burkhard, Oswald, et al.. (1982). Quantitative analyse der selbstassoziation von hämoglobinmolekülen anhand der konzentrationsabhängigkeit der spektren. Die Makromolekulare Chemie. 183(10). 2599–2610. 1 indexed citations

20.

Liptay, W., et al.. (1982). The Determination of Molecular Quantities from Measurements on Macroscopic Systems.II. The Determination of Electric Dipole Moments. Zeitschrift für Naturforschung A. 37(12). 1396–1408. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact